In conclusion, our study demonstrated that CHPF, a novel tumor-promoting gene in BRCA, can promote cell migration and invasion through the ECM and PI3K/AKT signaling pathways, ultimately altering the survival of BRCA patients. Here, CHPF is linked to neoplasm.